Skip to main content
Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis

Fig. 1

PRISMA flow diagram summarizing the process for study identification. 4993 articles were identified through the literature search. 4966 were excluded after the screening. 27 articles met eligibility criteria and were included for the analysis. HSCT: hematopoietic stem cell transplantation; CAR T-cell therapy: chimeric antigen receptor T-cell therapy

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us